EverSource Wealth Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Buy |
8,630
+3,103
| +56% | +$112K | 0.01% | 652 |
|
|
2025
Q1 | $172K | Buy |
5,527
+1,415
| +34% | +$44K | 0.01% | 709 |
|
|
2024
Q4 | $105K | Buy |
4,112
+818
| +25% | +$20.9K | 0.01% | 888 |
|
|
2024
Q3 | $93.2K | Buy |
3,294
+596
| +22% | +$16.9K | 0.01% | 814 |
|
|
2024
Q2 | $76K | Buy |
2,698
+655
| +32% | +$18.5K | 0.01% | 908 |
|
|
2024
Q1 | $56.6K | Buy |
2,043
+236
| +13% | +$6.54K | ﹤0.01% | 925 |
|
|
2023
Q4 | $50.8K | Buy |
1,807
+802
| +80% | +$22.5K | ﹤0.01% | 894 |
|
|
2023
Q3 | $27.3K | Buy |
1,005
+531
| +112% | +$14.4K | ﹤0.01% | 1020 |
|
|
2023
Q2 | $14.5K | Buy |
474
+175
| +59% | +$5.37K | ﹤0.01% | 1278 |
|
|
2023
Q1 | $10.8K | Buy |
299
+259
| +648% | +$9.33K | ﹤0.01% | 1317 |
|
|
2022
Q4 | $1.58K | Hold |
40
| – | – | ﹤0.01% | 1982 |
|
|
2022
Q3 | $2K | Hold |
40
| – | – | ﹤0.01% | 1718 |
|
|
2022
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 1555 |
|
|
2022
Q1 | $2K | Hold |
40
| – | – | ﹤0.01% | 1571 |
|
|
2021
Q4 | $2K | Buy |
+40
| New | +$2K | ﹤0.01% | 1612 |
|